Avalo Therapeutics AVTX
$6.76 +$0.01 (+0.15%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.76 0.00%
Open$6.65
Prev close$6.75
Day range$6.61 – $7.03
Volume1.18M
Market cap$390.88M
P/E (TTM)–
Dividend yield–
AVTX Stock News
Headlines matching Avalo Therapeutics or the AVTX ticker, most recent first.
- Guggenheim Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Cuts Target Price to $48 Negative
- A Quick Look at Today's Ratings for Avalo Therapeutics(AVTX.US), With a Forecast Between $30 to $58
- Leerink Partners Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $38
- BofA Securities Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $35
- TD Cowen Maintains Avalo Therapeutics(AVTX.US) With Buy Rating
- Stifel Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $36
- Guggenheim Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $50
- BTIG Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Raises Target Price to $58 Positive
- Citizens JMP Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Raises Target Price to $62 Positive
- BTIG Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $58
- A Quick Look at Today's Ratings for Avalo Therapeutics(AVTX.US), With a Forecast Between $34 to $55
- A Quick Look at Today's Ratings for Avalo Therapeutics(AVTX.US), With a Forecast Between $34 to $58
- Piper Sandler Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Raises Target Price to $60 Positive
- Wolfe Research Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $48
- Citizens JMP Initiates Avalo Therapeutics(AVTX.US) With Buy Rating, Announces Target Price $52
No comments yet — be the first to weigh in on AVTX.
Sign in to join the discussion.